Prognostic values of tissue-resident CD8+T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Table 1 The correlations between CD103⁺ cells, CD8⁺T cells, and CD103⁺CD8⁺T cells in tumor tissues and clinical features of patients with HCC

Clinical parameters	Cases	Numbers of infiltrating CD103⁺ cells		χ²	P	Numbers of infiltrating CD8⁺T cells		χ²	P	Numbers of infiltrating CD103⁺CD8⁺T cells		χ²	P	Ratio of CD103⁺CD8⁺T/CD8⁺T cells		χ²	P
		Low	High			Low	High			Low	High			Low	High
Gender
Male	84	38	46	0.00^a	1.00	17	67	0.09^a	0.76	42	42	0.74^a	0.39	32	57	0.01^a	0.98
Female	10	4	6			3	7			7	3			3	7
Age (years)
< 57	57	24	33	0.23	0.63	12	45	0.02	0.89	31	26	0.17	0.68	19	38	1.16	0.28
≥ 57	36	17	19			8	28			18	18			16	20
Tumor size (cm)
< 3.5	20	11	9	1.13	0.29	5	15	0.01^a	0.93	11	9	0.08	0.78	5	15	1.57^a	0.21
≥ 3.5	72	30	42			15	57			37	35			29	43
TNM stage
I + II	43	21	22	2.36	0.12	8	35	0.07	0.79	23	20	0.42	0.52	14	29	0.05	0.82
III + IV	43	14	29			9	34			20	23			15	28
T stage
I + II	43	21	22	2.36	0.12	8	35	0.07	0.79	23	20	0.42	0.52	14	29	0.05	0.82
III + IV	43	14	29			9	34			20	23			15	28
Pathological stage
I + II	57	26	31	0.05	0.82	13	44	0.20	0.65	33	24	1.93	0.17	16	41	5.20	0.02
III + IV	37	16	21			7	30			16	21			19	18

ISSN: 1477-7819